BFRI Earnings — Biofrontera Inc. Common Stock Post-ER Performance | BigEarnings
BFRI — Biofrontera Inc. Common Stock
XNAS · Healthcare · Drug Manufacturers - Specialty & Generic
Price$0.89
Market Cap$11.4M
P/E—
52W Range$0.55 – $1.19
Next Earnings2026-08-12
About Biofrontera Inc. Common Stock
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
